A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Conditions: Transthyretin Amyloid Cardiomyopathy Interventions: Drug: Tafamidis 61 milligrams Sponsors: Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiomyopathy | Heart | Learning | Pfizer | Research | Study | Universities & Medical Training